Career lifetime advances and key developments: diabetes.
Baglioni
Piero
P
Govindan
Jyothish
J
Khan
Afsha
A
D000588:Amines / Q000191:economics / Q000627:therapeutic use; D000639:Amitriptyline / Q000191:economics / Q000627:therapeutic use; D000700:Analgesics / Q000191:economics / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000191:economics / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000191:economics / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D000068736:Duloxetine Hydrochloride; D000077206:Gabapentin; D006801:Humans; D000069583:Pregabalin; D013876:Thiophenes / Q000191:economics / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D000928:Antidepressive Agents; D003509:Cyclohexanecarboxylic Acids; D013876:Thiophenes; D000639:Amitriptyline; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000068736:Duloxetine Hydrochloride